AMS Guidelines - klimik.org.tr€¦ · Germany-Austria 1 Antimicrobial Stewardship, ESGAP October...
Transcript of AMS Guidelines - klimik.org.tr€¦ · Germany-Austria 1 Antimicrobial Stewardship, ESGAP October...
AMS Guidelines: USA
Germany-Austria
1
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
Özlem Kurt Azap
Başkent University Faculty of Medicine
Infectious Diseases and Clinical Microbiology Dept.
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
2
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
3
• 2007, IDSA, Antimicrobial stewardship guideline
• 2014, CDC, Core elements of hospital antimicrobial stewardship programs
• 2015, White House, National Action Plan for Combating Antibiotic Resistant Bacteria
• 2016
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
4
In USA…
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
5
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
6
Total # recommendations: 28 # strong recommendations: 5 # weak recommendations: 18
# good practice recommendations: 5
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
7
Antimicrobial Stewardship, ESGAP October 2017, Istanbul 8
STRONG
WEAK
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
9
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
10
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
11
GOOD PRACTICE recommendation
Strong recommendations
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
12
Weak recommendations
Antimicrobial Stewardship, ESGAP October 2017, Istanbul 13
Weak recommendations
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
14
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
15
Weak recommendations
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
16
Weak recommendations
Good practice recommendations
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
17
Strong recommendations
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
18
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
19
Which method? Preauthorization? Prospective audit and feedback?
Implementing one of them is better than doing nothing!
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
20
Advantages…. Disadvantages….
Preauthorization
Faster reductions in inappropriate antibiotic use
Optimized empirical choices
Culture results are more commonly encountered while prescribing antibiotics
The cost of antibiotics are decreased
The direct “control” of antibiotics are obtained
Antimicrobial Stewardship, ESGAP October 2017, Istanbul 21
Advantages
Prospective audit and feedback ASP becomes more visible, helps building collegial relationships
Prescribers face more clinical data
Flexibility in timing of recommendations
Can be done less than daily
Educational benefit
Prescriber autonomy
Preauthorization Only restricted agents
Loss of prescriber autonomy
Delay in treatment
Potential for manipulation
Shift to other antibiotics
...
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
22
Disadvantages
Prospective audit and feedback Compliance voluntary
Labour intensive
Method of feedback is important
Reluctance to change therapy
It takes longer to achieve reductions in antibiotic use
...
Treatment durations
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
23
The shortest effective duration is the best!
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
24
Shorter vs Longer duration of antibiotics
Oral treatment
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
25
Oral treatment Initial therapy
Sequential therapy after iv usage
Advantages Lower cost
Shorter hospital stay
PK monitoring and adjustment program
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
26
PK monitoring programs for aminoglycosides
C.difficile
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
27
Avoidance of antibiotics with high risk for C.difficile
Infection control measures
Weak recommendations
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
28
Implementing AMS for spesific infectious diesases syndromes
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
29
Community acquired pneumonia
Hospital acquired pneumonia
Cellulitis Asymptomatic bacteriuria ……
Which measures?
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
30
Process measures Excess days of therapy Duration of therapy Compliance with algorithms Treatment revision based on
microbiological data Switch to oral therapy
Outcome measures Length of hospital stay 30 day mortality Adverse events due to atbs: C.difficile inf ..etc Clinical failure, recurrent infection
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
31
Stratified antibiograms
Antimicrobial susceptibility data based on departments, samples….etc
Antibiotic cycling
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
32
Antibiotic cycling is NOT RECOMMENDED!
Rapid diagnosis: Procalcitonin, viral antigen tests, fungal biomarkers,
molecular methods
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
33
Monitoring antibiotic use: DDD or DOT ?
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
34
DOT: Days of Therapy Not impacted by dose adjustments; can be used both for adults and pediatric patients
CDC requires DOT
Patient-level antibiotic data is required; not feasible at every facility
DDD: Daily Defined Dose Recommended by WHO
Easier than DOT
Widely used and offers comparability
Limited use in pediatrics
Stop orders
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
35
Good practice recommendations
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
36
‘End of life antibiotic treatment’
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
37
In terminally ill patients, ASPs should support clinicians in the decision of antibiotic treatment
In Europe…
• 2001, European Comission
• 2010, European Community, Antimicrobial resistance surveillance and monitoring antibiotic consumption
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
38
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
39
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
40
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
41
Recommendations: # A: 31 # B: 11 # C: 2
The team should consist of…
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
42
0.5 FTE for 250 beds FTE: Full time equivalent
Infectious diseases specialist Clinical pharmacist
Microbiology specialist Epidemiyologist Infection control consultant
Surveillance
Antimicrobial Stewardship, ESGAP October 2017, Istanbul 43
Resistance data should be accessible at least on yearly basis
Resistance data should be reported on department basis, sample basis..etc
Surveilance culture results should be reported seperately
Point prevelance surveys
Antibiotic consumption data: by AB class, top 5 or 10
Number of cultures per 1000 patient days: Blood, urine..
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
44
Quarterly use density (RDD/100patient days)
Targeted proactive audits of antiinfective use
Antimicrobial Stewardship, ESGAP October 2017, Istanbul 45
Point prevalance surveys Antibiotic use for Surgical prophylaxis
Bacteremia
Pneumonia at the Emergency Department
Sequential therapy; PE to oral
Hospital formulary is important!
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
46
Treatment optimisation
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
47
Optimisation of treatment does not necessarily mean de-escalation; sometimes requires escalation
Evaluation at 48-72 hours of therapy
Prolonged infusion of beta lactams…etc
TDM of antibiotics
Computerised information technology
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
48
Treatment guidelines Hospital formulary Surveillance results ….
should be readily electronically accessible
Gram negatif bakteriler için
ANTİMİKROBİYAL YÖNETİM REHBERİ
Hazırlayan: KLİMİK DERNEĞİ
Antimicrobial Stewardship, ESGAP October 2017, Istanbul
49